Rein Therapeutics, Inc.
RNTXBiotechnology
$0.73+1.67%As of Oct 29vs prior close
- Market cap
- $62.7M
- P/E (TTM)
- –
- From 52W high
- −61.35%
- EPS (YE25)
- -$1.96
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
12
Distressed LaggardBottom 3% of the scored universe
Growth—
Quality14
Value44
Momentum8
Resilience28
Growth
$0revenue, YE25
YE16 $0YE25 $0
Connections
Who owns it
1fund